false2022Q20001022652December 31P3YP3Y00010226522022-01-012022-06-3000010226522022-08-02xbrli:shares00010226522022-06-30iso4217:USD00010226522021-12-31iso4217:USDxbrli:shares0001022652us-gaap:SeriesEPreferredStockMember2022-06-300001022652us-gaap:SeriesEPreferredStockMember2021-12-310001022652insg:IoTAndMobileSolutionsMember2022-04-012022-06-300001022652insg:IoTAndMobileSolutionsMember2021-04-012021-06-300001022652insg:IoTAndMobileSolutionsMember2022-01-012022-06-300001022652insg:IoTAndMobileSolutionsMember2021-01-012021-06-300001022652insg:EnterpriseSaaSSolutionsMember2022-04-012022-06-300001022652insg:EnterpriseSaaSSolutionsMember2021-04-012021-06-300001022652insg:EnterpriseSaaSSolutionsMember2022-01-012022-06-300001022652insg:EnterpriseSaaSSolutionsMember2021-01-012021-06-3000010226522022-04-012022-06-3000010226522021-04-012021-06-3000010226522021-01-012021-06-300001022652us-gaap:PreferredStockMember2021-03-310001022652us-gaap:CommonStockMember2021-03-310001022652us-gaap:AdditionalPaidInCapitalMember2021-03-310001022652us-gaap:RetainedEarningsMember2021-03-310001022652us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001022652us-gaap:NoncontrollingInterestMember2021-03-3100010226522021-03-310001022652us-gaap:RetainedEarningsMember2021-04-012021-06-300001022652us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001022652us-gaap:CommonStockMember2021-04-012021-06-300001022652us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001022652us-gaap:CommonClassAMemberus-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001022652us-gaap:CommonClassAMember2021-04-012021-06-300001022652us-gaap:NoncontrollingInterestMember2021-04-012021-06-300001022652us-gaap:PreferredStockMember2021-06-300001022652us-gaap:CommonStockMember2021-06-300001022652us-gaap:AdditionalPaidInCapitalMember2021-06-300001022652us-gaap:RetainedEarningsMember2021-06-300001022652us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001022652us-gaap:NoncontrollingInterestMember2021-06-3000010226522021-06-300001022652us-gaap:PreferredStockMember2022-03-310001022652us-gaap:CommonStockMember2022-03-310001022652us-gaap:AdditionalPaidInCapitalMember2022-03-310001022652us-gaap:RetainedEarningsMember2022-03-310001022652us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001022652us-gaap:NoncontrollingInterestMember2022-03-3100010226522022-03-310001022652us-gaap:RetainedEarningsMember2022-04-012022-06-300001022652us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001022652us-gaap:CommonStockMember2022-04-012022-06-300001022652us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001022652us-gaap:PreferredStockMember2022-06-300001022652us-gaap:CommonStockMember2022-06-300001022652us-gaap:AdditionalPaidInCapitalMember2022-06-300001022652us-gaap:RetainedEarningsMember2022-06-300001022652us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001022652us-gaap:NoncontrollingInterestMember2022-06-300001022652us-gaap:PreferredStockMember2020-12-310001022652us-gaap:CommonStockMember2020-12-310001022652us-gaap:AdditionalPaidInCapitalMember2020-12-310001022652us-gaap:RetainedEarningsMember2020-12-310001022652us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001022652us-gaap:NoncontrollingInterestMember2020-12-3100010226522020-12-310001022652us-gaap:RetainedEarningsMember2021-01-012021-06-300001022652us-gaap:NoncontrollingInterestMember2021-01-012021-06-300001022652us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300001022652us-gaap:CommonStockMember2021-01-012021-06-300001022652us-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300001022652insg:ConvertibleSeniorNotesThreePointTwoFiveDue2025Memberus-gaap:CommonStockMember2021-01-012021-06-300001022652insg:ConvertibleSeniorNotesThreePointTwoFiveDue2025Memberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300001022652insg:ConvertibleSeniorNotesThreePointTwoFiveDue2025Member2021-01-012021-06-300001022652us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-01-012021-06-300001022652us-gaap:CommonClassAMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300001022652us-gaap:CommonClassAMember2021-01-012021-06-300001022652us-gaap:PreferredStockMember2021-12-310001022652us-gaap:CommonStockMember2021-12-310001022652us-gaap:AdditionalPaidInCapitalMember2021-12-310001022652us-gaap:RetainedEarningsMember2021-12-310001022652us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001022652us-gaap:RetainedEarningsMember2022-01-012022-06-300001022652us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001022652insg:ConvertibleSeniorNotesFivePointFiveZeroDue2022Memberus-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-300001022652insg:ConvertibleSeniorNotesFivePointFiveZeroDue2022Member2022-01-012022-06-300001022652us-gaap:CommonStockMember2022-01-012022-06-300001022652us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-300001022652us-gaap:SubsequentEventMemberus-gaap:RevolvingCreditFacilityMember2022-08-050001022652insg:SOFRMemberus-gaap:SubsequentEventMemberus-gaap:RevolvingCreditFacilityMember2022-08-052022-08-05xbrli:pure0001022652insg:SOFRMemberus-gaap:SubsequentEventMemberus-gaap:RevolvingCreditFacilityMembersrt:MinimumMember2022-08-052022-08-050001022652us-gaap:SubsequentEventMemberinsg:GreaterThan15MillionMemberus-gaap:RevolvingCreditFacilityMember2022-08-050001022652insg:SOFRMemberus-gaap:SubsequentEventMemberinsg:GreaterThan15MillionMemberus-gaap:RevolvingCreditFacilityMember2022-08-052022-08-050001022652insg:SOFRMemberus-gaap:SubsequentEventMemberinsg:GreaterThan15MillionMemberus-gaap:RevolvingCreditFacilityMembersrt:MinimumMember2022-08-052022-08-050001022652insg:GreaterThan25MillionMemberus-gaap:SubsequentEventMemberus-gaap:RevolvingCreditFacilityMember2022-08-050001022652insg:GreaterThan25MillionMemberinsg:SOFRMemberus-gaap:SubsequentEventMemberus-gaap:RevolvingCreditFacilityMember2022-08-052022-08-050001022652insg:GreaterThan25MillionMemberinsg:SOFRMemberus-gaap:SubsequentEventMemberus-gaap:RevolvingCreditFacilityMembersrt:MinimumMember2022-08-052022-08-050001022652us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberinsg:CtrackSouthAfricaMember2021-07-300001022652us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberinsg:CtrackSouthAfricaMember2021-07-302021-07-300001022652us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberinsg:CtrackSouthAfricaMember2021-10-292021-10-290001022652us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberinsg:CtrackSouthAfricaMember2021-10-290001022652insg:CanaccordGenuityLLCMember2021-01-2500010226522021-01-012021-01-3100010226522021-01-31insg:segment0001022652us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-06-300001022652us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMember2022-06-300001022652us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-06-300001022652us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2021-12-310001022652us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMember2021-12-310001022652us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2021-12-310001022652us-gaap:FairValueMeasurementsRecurringMember2022-06-300001022652us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300001022652us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001022652us-gaap:FairValueMeasurementsRecurringMember2021-12-310001022652us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001022652us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001022652us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2022-06-300001022652us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2022-06-300001022652us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2022-06-300001022652us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2021-12-310001022652us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2021-12-310001022652us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2021-12-310001022652us-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeMemberus-gaap:MeasurementInputPriceVolatilityMember2022-06-300001022652us-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeMemberus-gaap:MeasurementInputPriceVolatilityMember2021-12-310001022652us-gaap:MeasurementInputSharePriceMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeMember2022-06-300001022652us-gaap:MeasurementInputSharePriceMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeMember2021-12-310001022652us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputCreditSpreadMemberus-gaap:DerivativeMember2022-06-300001022652us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputCreditSpreadMemberus-gaap:DerivativeMember2021-12-310001022652us-gaap:MeasurementInputExpectedTermMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeMember2022-01-012022-06-300001022652us-gaap:MeasurementInputExpectedTermMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeMember2022-01-012022-03-310001022652us-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeMember2022-06-300001022652us-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeMember2021-12-310001022652us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:DerivativeMember2022-06-300001022652us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:DerivativeMember2021-12-310001022652us-gaap:ConvertibleDebtMemberinsg:TwentyTwentyFiveConvertibleNotesMember2020-05-120001022652us-gaap:ConvertibleDebtMemberinsg:TwentyTwentyFiveConvertibleNotesMember2022-06-300001022652us-gaap:ConvertibleDebtMemberinsg:TwentyTwentyFiveConvertibleNotesMember2020-05-122020-05-120001022652insg:TwentyTwentyFiveConvertibleNotesMember2021-01-012021-06-300001022652us-gaap:ConvertibleDebtMemberinsg:TwentyTwentyFiveConvertibleNotesMember2022-01-012022-06-30insg:trading_day0001022652us-gaap:ConvertibleDebtMemberinsg:TwentyTwentyFiveConvertibleNotesMember2021-12-310001022652us-gaap:ConvertibleDebtMemberinsg:TwentyTwentyFiveConvertibleNotesMember2022-04-012022-06-300001022652us-gaap:ConvertibleDebtMemberinsg:TwentyTwentyFiveConvertibleNotesMember2021-04-012021-06-300001022652us-gaap:ConvertibleDebtMemberinsg:TwentyTwentyFiveConvertibleNotesMember2021-01-012021-06-300001022652insg:A2018OmnibusIncentiveCompensationPlanMember2022-06-300001022652us-gaap:CostOfSalesMember2022-04-012022-06-300001022652us-gaap:CostOfSalesMember2021-04-012021-06-300001022652us-gaap:CostOfSalesMember2022-01-012022-06-300001022652us-gaap:CostOfSalesMember2021-01-012021-06-300001022652us-gaap:ResearchAndDevelopmentExpenseMember2022-04-012022-06-300001022652us-gaap:ResearchAndDevelopmentExpenseMember2021-04-012021-06-300001022652us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-06-300001022652us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-06-300001022652us-gaap:SellingAndMarketingExpenseMember2022-04-012022-06-300001022652us-gaap:SellingAndMarketingExpenseMember2021-04-012021-06-300001022652us-gaap:SellingAndMarketingExpenseMember2022-01-012022-06-300001022652us-gaap:SellingAndMarketingExpenseMember2021-01-012021-06-300001022652us-gaap:GeneralAndAdministrativeExpenseMember2022-04-012022-06-300001022652us-gaap:GeneralAndAdministrativeExpenseMember2021-04-012021-06-300001022652us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-06-300001022652us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-06-3000010226522022-01-012022-03-3100010226522021-01-012021-03-310001022652us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001022652us-gaap:EmployeeStockOptionMembersrt:MinimumMember2022-01-012022-06-300001022652us-gaap:EmployeeStockOptionMembersrt:MaximumMember2022-01-012022-06-300001022652us-gaap:EmployeeStockOptionMember2022-06-300001022652srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001022652srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001022652us-gaap:RestrictedStockUnitsRSUMember2021-12-310001022652us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001022652us-gaap:RestrictedStockUnitsRSUMember2022-06-300001022652us-gaap:ConvertibleDebtSecuritiesMember2022-04-012022-06-300001022652us-gaap:ConvertibleDebtSecuritiesMember2021-04-012021-06-300001022652us-gaap:ConvertibleDebtSecuritiesMember2022-01-012022-06-300001022652us-gaap:ConvertibleDebtSecuritiesMember2021-01-012021-06-300001022652us-gaap:WarrantMember2022-04-012022-06-300001022652us-gaap:WarrantMember2021-04-012021-06-300001022652us-gaap:WarrantMember2022-01-012022-06-300001022652us-gaap:WarrantMember2021-01-012021-06-300001022652us-gaap:EmployeeStockOptionMember2022-04-012022-06-300001022652us-gaap:EmployeeStockOptionMember2021-04-012021-06-300001022652us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001022652us-gaap:EmployeeStockOptionMember2021-01-012021-06-300001022652us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-06-300001022652us-gaap:RestrictedStockUnitsRSUMember2021-04-012021-06-300001022652us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001022652us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-06-300001022652insg:EmployeeStockPurchasePlanSecuritiesMember2022-04-012022-06-300001022652insg:EmployeeStockPurchasePlanSecuritiesMember2021-04-012021-06-300001022652insg:EmployeeStockPurchasePlanSecuritiesMember2022-01-012022-06-300001022652insg:EmployeeStockPurchasePlanSecuritiesMember2021-01-012021-06-300001022652insg:TwoThousandNineteenWarrantsMember2019-03-280001022652insg:UnitedStatesAndCanadaMember2022-04-012022-06-300001022652insg:UnitedStatesAndCanadaMember2021-04-012021-06-300001022652insg:UnitedStatesAndCanadaMember2022-01-012022-06-300001022652insg:UnitedStatesAndCanadaMember2021-01-012021-06-300001022652srt:EuropeMember2022-04-012022-06-300001022652srt:EuropeMember2021-04-012021-06-300001022652srt:EuropeMember2022-01-012022-06-300001022652srt:EuropeMember2021-01-012021-06-300001022652country:ZA2022-04-012022-06-300001022652country:ZA2021-04-012021-06-300001022652country:ZA2022-01-012022-06-300001022652country:ZA2021-01-012021-06-300001022652insg:OtherGeographicRegionsMember2022-04-012022-06-300001022652insg:OtherGeographicRegionsMember2021-04-012021-06-300001022652insg:OtherGeographicRegionsMember2022-01-012022-06-300001022652insg:OtherGeographicRegionsMember2021-01-012021-06-300001022652us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberinsg:CustomerOneMember2022-04-012022-06-300001022652us-gaap:SalesRevenueNetMemberinsg:CustomerTwoMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-06-300001022652us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberinsg:CustomerOneMember2021-04-012021-06-300001022652us-gaap:SalesRevenueNetMemberinsg:CustomerTwoMemberus-gaap:CustomerConcentrationRiskMember2021-04-012021-06-300001022652us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberinsg:CustomerOneMember2022-01-012022-06-300001022652us-gaap:SalesRevenueNetMemberinsg:CustomerTwoMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-06-300001022652us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberinsg:CustomerOneMember2021-01-012021-06-300001022652us-gaap:SalesRevenueNetMemberinsg:CustomerTwoMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-06-300001022652us-gaap:CreditConcentrationRiskMemberus-gaap:AccountsReceivableMemberinsg:CustomerOneMember2022-01-012022-06-300001022652insg:CustomerTwoMemberus-gaap:CreditConcentrationRiskMemberus-gaap:AccountsReceivableMember2022-01-012022-06-300001022652us-gaap:CreditConcentrationRiskMemberus-gaap:AccountsReceivableMemberinsg:CustomerOneMember2022-01-012022-03-310001022652insg:CustomerTwoMemberus-gaap:CreditConcentrationRiskMemberus-gaap:AccountsReceivableMember2022-01-012022-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
| | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2022
OR
| | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to .
Commission File Number: 001-38358
| | | | | |
| INSEEGO CORP. |
| (Exact name of registrant as specified in its charter) |
| | | | | | | | | | | |
Delaware | | 81-3377646 |
(State or Other Jurisdiction of Incorporation or Organization) | | (I.R.S. Employer Identification No.) |
| | |
9710 Scranton Road, Suite 200 | | |
San Diego, | California | | 92121 |
(Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (858) 812-3400
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock, par value $0.001 per share | INSG | Nasdaq Global Select Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | |
Large accelerated filer | ☒ | Accelerated filer | ☐ |
Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The number of shares of the registrant’s common stock outstanding as of August 2, 2022 was 107,665,368.
TABLE OF CONTENTS
| | | | | | | | |
| Page |
| |
| | |
Item 1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| Condensed Consolidated Statements of Cash Flows (Unaudited) | |
| | |
| | |
| | |
Item 2. | | |
| | |
Item 3. | | |
| | |
Item 4. | | |
| |
| |
| | |
Item 1. | | |
| | |
Item 1A. | | |
| | |
Item 2. | | |
| | |
Item 3. | | |
| | |
Item 4. | | |
| |
Item 5. | | |
| |
Item 6. | | |
| |
| |
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements.
INSEEGO CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except par value and share data)
| | | | | | | | | | | |
| June 30, 2022 | | December 31, 2021 |
| (Unaudited) | | |
ASSETS | | | |
Current assets: | | | |
Cash and cash equivalents | $ | 21,090 | | | $ | 46,474 | |
Restricted cash | 3,270 | | | 3,338 | |
Accounts receivable, net of allowance for doubtful accounts of $343 and $408, respectively | 22,491 | | | 26,781 | |
| | | |
Inventories | 46,977 | | | 37,402 | |
| | | |
Prepaid expenses and other | 10,424 | | | 13,624 | |
| | | |
| | | |
Total current assets | 104,252 | | | 127,619 | |
Property, plant and equipment, net of accumulated depreciation of $24,124 and $26,692, respectively | 6,930 | | | 8,102 | |
Rental assets, net of accumulated depreciation of $6,476 and $5,392, respectively | 4,613 | | | 4,575 | |
Intangible assets, net of accumulated amortization of $58,807 and $48,404, respectively | 46,008 | | | 46,995 | |
| | | |
Goodwill | 21,922 | | | 20,336 | |
Right-of-use assets, net | 6,985 | | | 7,839 | |
Other assets | 566 | | | 377 | |
Total assets | $ | 191,276 | | | $ | 215,843 | |
LIABILITIES AND STOCKHOLDERS’ DEFICIT | | | |
Current liabilities: | | | |
Accounts payable | $ | 45,640 | | | $ | 48,577 | |
Accrued expenses and other current liabilities | 24,298 | | | 26,253 | |
| | | |
| | | |
| | | |
| | | |
| | | |
Total current liabilities | 69,938 | | | 74,830 | |
Long-term liabilities: | | | |
| | | |
2025 Notes, net | 157,708 | | | 157,866 | |
| | | |
| | | |
| | | |
Deferred tax liabilities, net | 864 | | | 852 | |
Other long-term liabilities | 6,456 | | | 7,149 | |
Total liabilities | 234,966 | | | 240,697 | |
Commitments and contingencies | | | |
Stockholders’ deficit: | | | |
Preferred stock, par value $0.001; 2,000,000 shares authorized: | | | |
Series E Preferred stock, par value $0.001; 39,500 shares designated, 25,000 shares issued and outstanding, liquidation preference of $1,000 per share (plus any accrued but unpaid dividends) | — | | | — | |
Common stock, par value $0.001; 150,000,000 shares authorized, 107,645,213 and 105,380,533 shares issued and outstanding, respectively | 108 | | | 105 | |
Additional paid-in capital | 787,283 | | | 770,619 | |
Accumulated other comprehensive loss | (5,097) | | | (8,531) | |
Accumulated deficit | (825,984) | | | (787,047) | |
| | | |
| | | |
| | | |
Total stockholders’ deficit | (43,690) | | | (24,854) | |
Total liabilities and stockholders’ deficit | $ | 191,276 | | | $ | 215,843 | |
See accompanying notes to unaudited condensed consolidated financial statements.
INSEEGO CORP.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | | | Six Months Ended June 30, |
| 2022 | | 2021 | | | | 2022 | | 2021 |
Net revenues: | | | | | | | | | |
IoT & Mobile Solutions | $ | 54,990 | | | $ | 51,836 | | | | | $ | 109,495 | | | $ | 94,795 | |
Enterprise SaaS Solutions | 6,866 | | | 13,857 | | | | | 13,745 | | | 28,495 | |
Total net revenues | 61,856 | | | 65,693 | | | | | 123,240 | | | 123,290 | |
Cost of net revenues: | | | | | | | | | |
IoT & Mobile Solutions | 40,694 | | | 39,740 | | | | | 83,597 | | | 73,178 | |
Enterprise SaaS Solutions | 3,270 | | | 5,604 | | | | | 6,503 | | | 11,288 | |
| | | | | | | | | |
Total cost of net revenues | 43,964 | | | 45,344 | | | | | 90,100 | | | 84,466 | |
Gross profit | 17,892 | | | 20,349 | | | | | 33,140 | | | 38,824 | |
Operating costs and expenses: | | | | | | | | | |
Research and development | 13,619 | | | 11,773 | | | | | 32,179 | | | 26,328 | |
Sales and marketing | 7,721 | | | 9,821 | | | | | 17,494 | | | 20,825 | |
General and administrative | 6,142 | | | 7,414 | | | | | 14,380 | | | 16,058 | |
Amortization of purchased intangible assets | 443 | | | 664 | | | | | 887 | | | 1,130 | |
Impairment of capitalized software | — | | | 1,197 | | | | | — | | | 1,197 | |
| | | | | | | | | |
| | | | | | | | | |
Total operating costs and expenses | 27,925 | | | 30,869 | | | | | 64,940 | | | 65,538 | |
Operating loss | (10,033) | | | (10,520) | | | | | (31,800) | | | (26,714) | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Loss on debt conversion and extinguishment, net | — | | | — | | | | | (450) | | | (432) | |
Interest expense, net | (1,664) | | | (1,678) | | | | | (4,587) | | | (3,523) | |
Other (expense) income, net | (982) | | | (617) | | | | | (1,387) | | | 1,117 | |
Loss before income taxes | (12,679) | | | (12,815) | | | | | (38,224) | | | (29,552) | |
Income tax (benefit) provision | (303) | | | 228 | | | | | (625) | | | 449 | |
| | | | | | | | | |
| | | | | | | | | |
Net loss | (12,376) | | | (13,043) | | | | | (37,599) | | | (30,001) | |
Less: Net income attributable to noncontrolling interests | — | | | — | | | | | — | | | (214) | |
Net loss attributable to Inseego Corp. | (12,376) | | | (13,043) | | | | | (37,599) | | | (30,215) | |
Series E preferred stock dividends | (677) | | | (886) | | | | | (1,338) | | | (1,753) | |
Net loss attributable to common stockholders | $ | (13,053) | | | $ | (13,929) | | | | | $ | (38,937) | | | $ | (31,968) | |
Per share data: | | | | | | | | | |
Net loss per common share: | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Basic and diluted | $ | (0.12) | | | $ | (0.14) | | | | | $ | (0.37) | | | $ | (0.31) | |
| | | | | | | | | |
| | | | | | | | | |
Weighted-average shares used in computation of net loss per common share: | | | | | | | | | |
Basic and diluted | 107,511,660 | | | 102,935,213 | | | | | 106,585,684 | | | 102,157,146 | |
| | | | | | | | | |
| | | | | | | | | |
See accompanying notes to unaudited condensed consolidated financial statements.
INSEEGO CORP.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In thousands)
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | | | Six Months Ended June 30, |
| 2022 | | 2021 | | | | 2022 | | 2021 |
Net loss | $ | (12,376) | | | $ | (13,043) | | | | | $ | (37,599) | | | $ | (30,001) | |
Foreign currency translation adjustment | 536 | | | 2,425 | | | | | 3,434 | | | 693 | |
| | | | | | | | | |
Total comprehensive loss | $ | (11,840) | | | $ | (10,618) | | | | | $ | (34,165) | | | $ | (29,308) | |
Comprehensive income attributable to noncontrolling interests | — | | | — | | | | | — | | | (214) | |
Comprehensive loss attributable to Inseego Corp. | $ | (11,840) | | | $ | (10,618) | | | | | $ | (34,165) | | | $ | (29,522) | |
See accompanying notes to unaudited condensed consolidated financial statements.
INSEEGO CORP.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
(In thousands)
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Preferred Stock | | Common Stock | | Additional Paid-in Capital | | | | Accumulated Deficit | | Accumulated Other Comprehensive Income (Loss) | | Noncontrolling Interests | | Total Stockholders’ Equity (Deficit) |
| Shares | | Amount | | Shares | | Amount | | | | | | |
Balance, March 31, 2021 | 35 | | | $ | — | | | 102,773 | | | $ | 103 | | | $ | 757,352 | | | | | $ | (750,221) | | | (8,704) | | | $ | 7 | | | $ | (1,463) | |
Net loss | — | | | — | | | — | | | — | | | — | | | | | (13,043) | | | — | | | — | | | (13,043) | |
Foreign currency translation adjustment | — | | | — | | | — | | | — | | | — | | | | | — | | | 2,425 | | | — | | | 2,425 | |
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan | — | | | — | | | 336 | | | — | | | 1,282 | | | | | — | | | — | | | — | | | 1,282 | |
Taxes withheld on net settled vesting of restricted stock units | — | | | — | | | — | | | — | | | (356) | | | | | — | | | — | | | — | | | (356) | |
| | | | | | | | | | | | | | | | | | | |
Issuance of common shares in connection with a public offering, net of issuance costs | — | | | — | | | — | | | — | | | (59) | | | | | — | | | — | | | — | | | (59) | |
Share-based compensation | — | | | — | | | — | | | — | | | 2,307 | | | | | — | | | — | | | — | | | 2,307 | |
Net noncontrolling interest acquired | — | | | — | | | — | | | — | | | — | | | | | — | | | — | | | 1 | | | 1 | |
Series E preferred stock dividends | — | | | — | | | — | | | — | | | 886 | | | | | (886) | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | | | | |
Balance, June 30, 2021 | 35 | | | $ | — | | | 103,109 | | | $ | 103 | | | $ | 761,412 | | | | | $ | (764,150) | | | $ | (6,279) | | | $ | 8 | | | $ | (8,906) | |
| | | | | | | | | | | | | | | | | | | |
Balance, March 31, 2022 | 25 | | | $ | — | | | 107,389 | | | $ | 107 | | | $ | 784,267 | | | | | $ | (812,931) | | | $ | (5,633) | | | $ | — | | | $ | (34,190) | |
Net loss | — | | | — | | | — | | | — | | | — | | | | | $ | (12,376) | | | — | | | — | | | (12,376) | |
Foreign currency translation adjustment | — | | | — | | | — | | | — | | | — | | | | | $ | — | | | 536 | | | — | | | 536 | |
| | | | | | | | | | | | | | | | | | | |
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan | — | | | — | | | 256 | | | 1 | | | 74 | | | | | $ | — | | | — | | | — | | | 75 | |
Taxes withheld on net settled vesting of restricted stock units | — | | | — | | | — | | | — | | | (22) | | | | | $ | — | | | — | | | — | | | (22) | |
Share-based compensation | — | | | — | | | — | | | — | | | 2,287 | | | | | $ | — | | | — | | | — | | | 2,287 | |
Series E preferred stock dividends | — | | | — | | | — | | | — | | | 677 | | | | | (677) | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | | | | |
Balance, June 30, 2022 | 25 | | | $ | — | | | 107,645 | | | $ | 108 | | | $ | 787,283 | | | | | $ | (825,984) | | | $ | (5,097) | | | $ | — | | | $ | (43,690) | |
INSEEGO CORP.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
(In thousands)
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Preferred Stock | | Common Stock | | Additional Paid-in Capital | | | | Accumulated Deficit | | Accumulated Other Comprehensive Income (Loss) | | Noncontrolling Interests | | Total Stockholders’ Deficit |
| Shares | | Amount | | Shares | | Amount | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Balance, December 31, 2020 | 35 | | | $ | — | | | 99,399 | | | $ | 99 | | | $ | 711,487 | | | | | $ | (732,422) | | | $ | (6,972) | | | $ | (91) | | | $ | (27,899) | |
Net loss | — | | | — | | | — | | | — | | | — | | | | | (30,215) | | | — | | | 214 | | | (30,001) | |
Foreign currency translation adjustment | — | | | — | | | — | | | — | | | — | | | | | — | | | 693 | | | — | | | 693 | |
| | | | | | | | | | | | | | | | | | | |
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan | — | | | — | | | 1,765 | | | 2 | | | 2,842 | | | | | — | | | — | | | — | | | 2,844 | |
Taxes withheld on net settled vesting of restricted stock units | — | | | — | | | — | | | — | | | (825) | | | | | — | | | — | | | — | | | (825) | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Issuance of common shares in connection with the conversion of 2025 Notes | — | | | — | | | 429 | | | 1 | | | 5,382 | | | | | — | | | — | | | — | | | 5,383 | |
Issuance of common shares in connection with a public offering, net of issuance costs | — | | | — | | | 1,516 | | | 1 | | | 29,368 | | | | | — | | | — | | | — | | | 29,369 | |
| | | | | | | | | | | | | | | | | | | |
Share-based compensation | — | | | — | | | — | | | — | | | 11,405 | | | | | — | | | — | | | — | | | 11,405 | |
Series E preferred stock dividends | — | | | — | | | — | | | — | | | 1,753 | | | | | (1,753) | | | — | | | — | | | — | |
Net noncontrolling interest acquired | — | | | — | | | — | | | — | | | — | | | | | 240 | | | — | | | (115) | | | 125 | |
Balance, June 30, 2021 | 35 | | | — | | | 103,109 | | | $ | 103 | | | $ | 761,412 | | | | | $ | (764,150) | | | $ | (6,279) | | | $ | 8 | | | $ | (8,906) | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Balance, December 31, 2021 | 25 | | | $ | — | | | 105,381 | | | $ | 105 | | | $ | 770,619 | | | | | $ | (787,047) | | | $ | (8,531) | | | $ | — | | | $ | (24,854) | |
Net loss | — | | | — | | | — | | | — | | | — | | | | | (37,599) | | | — | | | — | | | (37,599) | |
Foreign currency translation adjustment | — | | | — | | | — | | | — | | | — | | | | | — | | | 3,434 | | | — | | | 3,434 | |
Adjustment relating to extinguishment of 2022 Notes | | | | | | | | | 1,728 | | | | | — | | | — | | | — | | | 1,728 | |
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan | — | | | — | | | 2,269 | | | 3 | | | 148 | | | | | — | | | — | | | — | | | 151 | |
Taxes withheld on net settled vesting of restricted stock units | — | | | — | | | (5) | | | — | | | (36) | | | | | — | | | — | | | — | | | (36) | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Share-based compensation | — | | | — | | | — | | | — | | | 13,486 | | | | | — | | | — | | | — | | | 13,486 | |
Series E preferred stock dividends | — | | | — | | | — | | | — | | | 1,338 | | | | | (1,338) | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Balance, June 30, 2022 | 25 | | | $ | — | | | 107,645 | | | $ | 108 | | | $ | 787,283 | | | | | $ | (825,984) | | | $ | (5,097) | | | $ | — | | | $ | (43,690) | |
INSEEGO CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited) | | | | | | | | | | | |
| Six Months Ended June 30, |
| 2022 | | 2021 |
Cash flows from operating activities: | | | |
Net loss | $ | (37,599) | | | $ | (30,001) | |
Adjustments to reconcile net loss to net cash used in operating activities: | | | |
Depreciation and amortization | 13,955 | | | 13,051 | |
(Recoveries) provision for bad debts | (15) | | | 266 | |
Impairment of capitalized software | — | | | 1,197 | |
Provision for excess and obsolete inventory | 896 | | | 496 | |
Share-based compensation expense | 13,486 | | | 11,405 | |
| | | |
Amortization of debt discount and debt issuance costs | 2,022 | | | 746 | |
Fair value adjustment on derivative instrument | (902) | | | (1,823) | |
Loss on debt conversion and extinguishment, net | 450 | | | 432 | |
| | | |
Deferred income taxes | (96) | | | 38 | |
Right-of-use assets | 1,070 | | | 883 | |
Other | — | | | (330) | |
Changes in assets and liabilities, net of effects of divestiture: | | | |
Accounts receivable | 5,239 | | | 6,483 | |
Inventories | (10,148) | | | (834) | |
Prepaid expenses and other assets | 3,100 | | | 1,158 | |
Accounts payable | (6,207) | | | (16,015) | |
Accrued expenses, income taxes, and other | (1,740) | | | 2,180 | |
Operating lease liabilities | (1,109) | | | (1,362) | |
Net cash used in operating activities | (17,598) | | | (12,030) | |
Cash flows from investing activities: | | | |
Acquisition of noncontrolling interest | — | | | (116) | |
Purchases of property, plant and equipment | (1,059) | | | (2,455) | |
Proceeds from the sale of property, plant and equipment | — | | | 506 | |
| | | |
Additions to capitalized software development costs | (6,222) | | | (15,369) | |
Net cash used in investing activities | (7,281) | | | (17,434) | |
Cash flows from financing activities: | | | |
| | | |
| | | |
Net borrowing of bank and overdraft facilities | (139) | | | 295 | |
Principal payments under finance lease obligations | (62) | | | (2,173) | |
Proceeds from a public offering, net of issuance costs | — | | | 29,369 | |
Principal payments on financed assets | (1,231) | | | — | |
Proceeds from stock option exercises and employee stock purchase plan, net of taxes paid on vested restricted stock units | 115 | | | 2,020 | |
Net cash (used in) provided by financing activities | (1,317) | | | 29,511 | |
Effect of exchange rates on cash | 744 | | | 321 | |
Net (decrease) increase in cash, cash equivalents and restricted cash | (25,452) | | | 368 | |
Cash, cash equivalents and restricted cash, beginning of period | 49,812 | | | 40,015 | |
Cash, cash equivalents and restricted cash, end of period | $ | 24,360 | | | $ | 40,383 | |
Supplemental disclosures of cash flow information: | | | |
Cash paid during the year for: | | | |
Interest | $ | 2,631 | | | $ | 2,782 | |
Income taxes | $ | 26 | | | $ | 252 | |
| | | |
Supplemental disclosures of non-cash activities: | | | |
Transfer of inventories to rental assets | $ | 134 | | | $ | 3,403 | |
Capital expenditures financed through accounts payable or accrued liabilities | $ | 3,228 | | | $ | 3,641 | |
Right-of-use assets obtained in exchange for operating leases liabilities | $ | 158 | | | $ | 148 | |
| | | |
| | | |
| | | |
| | | |
| | | |
2025 Notes conversion, including shares issued in satisfaction of interest make-whole payment | $ | — | | | $ | 5,383 | |
| | | |
| | | |
| | | |
| | | |
See accompanying notes to unaudited condensed consolidated financial statements.
INSEEGO CORP.
Notes to Condensed Consolidated Financial Statements (Unaudited)
1. Basis of Presentation
The information contained herein has been prepared by Inseego Corp. (the “Company”) in accordance with the rules of the Securities and Exchange Commission (the “SEC”). The information at June 30, 2022 and the results of the Company’s operations for the three and six months ended June 30, 2022 and 2021 are unaudited. The condensed consolidated financial statements reflect all adjustments, consisting of only normal recurring accruals, except otherwise disclosed herein, which are, in the opinion of management, necessary for a fair statement of the results of the interim periods presented. These unaudited condensed consolidated financial statements and notes hereto should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The year-end condensed consolidated balance sheet data as of December 31, 2021 was derived from the Company’s audited consolidated financial statements and may not include all disclosures required by accounting principles generally accepted in the United States. Certain prior period amounts were reclassified to conform to the current period presentation. These reclassifications did not affect total revenues, costs and expenses, net loss, assets, liabilities or stockholders’ deficit. Except as set forth below, the accounting policies used in preparing these unaudited condensed consolidated financial statements are the same as those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for any other interim period or for the year as a whole.
Risks and Uncertainties
In December 2019, the novel coronavirus (“COVID-19”) was reported to have surfaced in Wuhan, China, resulting in shutdowns of manufacturing and commerce globally in the months that followed. Since then, the COVID-19 pandemic has spread worldwide, and has resulted in authorities implementing numerous measures to try to contain the disease or slow its spread, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns. The extent of the impact of the COVID-19 pandemic on the Company’s operational and financial performance will depend on future developments, including the duration and spread of the pandemic and related actions taken by the U.S. government, state and local government officials, and international governments to prevent the spread of the disease, all of which are uncertain and cannot be predicted.
In addition, a global semiconductor supply shortage is having wide-ranging effects across the technology industry. This semiconductor shortage has not materially impacted the Company but may impact the Company’s customers, and may negatively impact the supply of materials needed for our testing and production timeline. Our suppliers, contract manufacturers, and our customers are all taking actions to reduce the impact of the semiconductor shortage; however, if the shortage persists, the impact on our business could be material.
Liquidity
As of June 30, 2022, the Company had available cash and cash equivalents totaling $21.1 million, excluding restricted cash of $3.3 million.
On August 5, 2022, Inseego Corp. (“Inseego” or the “Company”) entered into a Loan and Security Agreement (the “Credit Agreement”), by and among Siena Lending Group LLC, as lender (“Lender”), Inseego Wireless, Inc., a Delaware corporation (“Inseego Wireless”), and Inseego North America LLC, an Oregon limited liability company, as borrowers (“Inseego North America” and, together with Inseego Wireless, the “Borrowers”), and the Company, as guarantor (together with the Borrowers, the “Loan Parties”). The Credit Agreement establishes a secured asset-backed revolving credit facility which is comprised of a $50 million revolving credit facility (the “Credit Facility”), with a minimum draw of $4.5 million upon execution of the Credit Agreement. The Credit Facility matures on December 31, 2024. Availability under the Credit Facility is determined by a Borrowing Base (as defined in the Credit Agreement) comprised of a percentage of eligible accounts receivable and eligible inventory of the Borrowers. The Borrowers’ obligations under the Credit Agreement are guaranteed by the Company. The Loan Parties’ obligations under the Credit Agreement are secured by a continuing security interest in all property of each Loan Party, subject to certain Excluded Collateral (as defined in the Credit Agreement).
Borrowings under the Credit Facility may take the form of base rate loans or Secured Overnight Financing Rate (“SOFR”) loans. SOFR loans will bear interest at a rate per annum equal to Term SOFR (as defined in the Credit Agreement) plus an adjustment based on the outstanding amount for a preceding month. If the outstanding amount for a preceding month is less than $15 million, the interest rate on the Credit Agreement is Term SOFR (as defined in the Credit Agreement) plus 3.50%, with a Term SOFR floor of 1.00%. If the outstanding amount for a preceding month is greater than $15 million, the interest rate is calculated by Term SOFR plus 4.00%, with a Term SOFR floor of 1.00%. If the outstanding amount for a preceding month is greater than $25 million, the interest rate is calculated by Term SOFR plus 5.50%, with a Term SOFR floor of 1.00%. The Credit Agreement is also subject to closing costs and financial covenants.
INSEEGO CORP.
Notes to Condensed Consolidated Financial Statements (Unaudited)
On July 30, 2021, the Company completed the sale of its Ctrack business operations in Africa, Pakistan and the Middle East (together “Ctrack South Africa”). Initial cash proceeds of approximately $36.6 million were received. Net cash proceeds received were $31.5 million, net of cash divested of $5.0 million. Final cash proceeds were subject to certain post-closing working capital adjustments which totaled $2.6 million, out of which $2.2 million was received on October 29, 2021, and the remaining $0.4 million was offset with the Company’s existing accounts payable balance to an affiliate of Convergence Partners (“Convergence”), an investment management firm in South Africa.
On January 25, 2021, the Company entered into an Equity Distribution Agreement with Canaccord Genuity LLC (the “Agent”), pursuant to which the Company may offer and sell, from time to time, through or to the Agent, up to $40.0 million of shares of its common stock (the “ATM Offering”). In January 2021, the Company sold 1,516,073 shares of common stock, at an average price of $20.11 per share, for net proceeds of $29.4 million, after deducting underwriter fees and discounts of $0.9 million, and other offering fees, pursuant to the ATM Offering.
The Company has a history of operating and net losses and overall usage of cash from operating and investing activities. The Company’s management believes that its cash and cash equivalents, together with anticipated cash flows from operations, will be sufficient to meet its cash flow needs for the next twelve months from the filing date of this report. The Company’s ability to attain more profitable operations and continue to generate positive cash flow is dependent upon achieving a level and mix of revenues adequate to support its evolving cost structure. If events or circumstances occur such that the Company does not meet its operating plan as expected, or if the Company becomes obligated to pay unforeseen expenditures as a result of ongoing litigation, the Company may be required to raise capital, reduce planned research and development activities, incur additional restructuring charges or reduce other operating expenses which could have an adverse impact on its ability to achieve its intended business objectives.
The Company’s liquidity could be impaired if there is any interruption in its business operations, a material failure to satisfy its contractual commitments or a failure to generate revenue from new or existing products. There can be no assurance that any required or desired restructuring or financing will be available on terms favorable to the Company, or at all. Additionally, the Company is uncertain of the full extent to which the COVID-19 pandemic will impact the Company’s business, operations and financial results.
Principles of Consolidation
The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Segment Information
Management has determined that the Company has one reportable segment. The Chief Executive Officer, who is also the Chief Operating Decision Maker, does not manage any part of the Company separately, and the allocation of resources and assessment of performance is based solely on the Company’s consolidated operations and operating results.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent liabilities. Actual results could differ materially from these estimates. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the COVID-19 pandemic could have on our significant accounting estimates. Significant estimates include revenue recognition, capitalized software costs, allowance for credit losses, provision for excess and obsolete inventory, valuation of intangible and long-lived assets, valuation of goodwill, valuation of derivatives, accruals relating to litigation, income taxes and share-based compensation expense.
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents include highly liquid investments with original maturities of three months or less. The Company’s cash and cash equivalents are generally held with large financial institutions worldwide to reduce the amount of exposure to any credit risk. Restricted cash consists of Company funds in escrow with a financial institution as collateral for potential future uninsured warranty claims related to the divestiture of Ctrack South Africa. Cash, cash equivalents and restricted cash are recorded at market value, which approximates cost. Gains and losses associated with the Company’s foreign currency denominated demand deposits are recorded as a component of other income, net, in the consolidated statements of operations. The following table provides a reconciliation of cash, cash equivalents and restricted cash as reported within the consolidated balance sheets to “Cash, cash equivalents, and restricted cash, end of period” as reported within the consolidated
INSEEGO CORP.
Notes to Condensed Consolidated Financial Statements (Unaudited)
statements of cash flows (in thousands): | | | | | | | | | | | |
| June 30, 2022 | | December 31, 2021 |
|
Cash and cash equivalents | $ | 21,090 | | | $ | 46,474 | |
Restricted cash | 3,270 | | | 3,338 | |
Cash, cash equivalents and restricted cash, end of period | $ | 24,360 | | | $ | 49,812 | |
Recently Adopted Accounting Pronouncements
In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40)-Accounting For Convertible Instruments and Contracts in an Entity's Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for annual and interim periods beginning after December 15, 2021. The Company adopted this standard in the first quarter of fiscal 2022 and it did not have an impact to the condensed consolidated financial statements.
In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The new ASU addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This amendment is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company adopted this standard in the first quarter of fiscal 2022 and it did not have an impact to the condensed consolidated financial statements.
Recent Accounting Pronouncements Not Yet Adopted
Other than the above mentioned recently adopted accounting pronouncements, there have been no recent accounting pronouncements, changes in accounting pronouncements or recent accounting pronouncements not yet adopted during the six months ended June 30, 2022 that are of significance or potential significance to the Company’s financial position, results of operations and cash flows.
2. Financial Statement Details
Inventories
Inventories, net, consist of the following (in thousands):
| | | | | | | | | | | |
| June 30, 2022 | | December 31, 2021 |
Finished goods | $ | 38,978 | | | $ | 33,112 | |
Raw materials and components | 7,999 | | | 4,290 | |
Total inventories | $ | 46,977 | | | $ | 37,402 | |
INSEEGO CORP.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Prepaid expenses and other
Prepaid expenses and other consists of the following (in thousands):
| | | | | | | | | | | |
| June 30, 2022 | | December 31, 2021 |
|
Rebate receivables | $ | 3,569 | | | $ | 6,398 | |
Receivables from contract manufacturers | 1,671 | | | 2,626 | |
Software licenses | 1,777 | | | 1,261 | |
Insurance | 368 | | | 1,269 | |
Deposits | 1,006 | | | 1,023 | |
Financed assets | 655 | | | 323 | |
Other | 1,378 | | | 724 | |
| $ | 10,424 | | | $ | 13,624 | |
Accrued expenses and other current liabilities
Accrued expenses and other current liabilities consist of the following (in thousands):
| | | | | | | | | | | |
| June 30, 2022 | | December 31, 2021 |
Royalties | $ | 1,762 | | | $ | 2,243 | |
Payroll and related expenses | 9,092 | | | 9,326 | |
Warranty obligations | 480 | | | 473 | |
Professional fees | 548 | | | 502 | |
Bank overdrafts | 231 | | | 370 | |
Accrued interest | 877 | | | 877 | |
| | | |
| | | |
Contract liabilities | 5,042 | | | 3,832 | |
Operating lease liabilities | 1,580 | | | 1,769 | |
Accrued contract manufacturing liabilities | 999 | | | 927 | |
Liabilities related to financed assets | 272 | | | 1,593 | |
Value added tax payables | 394 | | | 642 | |
Other | 3,021 | | | 3,699 | |
Total accrued expenses and other current liabilities | $ | 24,298 | | | $ | 26,253 | |
3. Fair Value Measurement of Assets and Liabilities
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). A fair value measurement reflects the assumptions market participants would use in pricing an asset or liability based on the best available information. These assumptions include the risk inherent in a particular valuation technique (such as a pricing model) and the risks inherent in the inputs to the model.
The Company classifies inputs to measure fair value using a three-level hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) and is defined as follows:
Level 1: Pricing inputs are based on quoted market prices for identical assets or liabilities in active markets (e.g., NYSE or NASDAQ). Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.
INSEEGO CORP.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Level 2: Pricing inputs include benchmark yields, trade data, reported trades and broker dealer quotes, two-sided markets and industry and economic events, yield to maturity, Municipal Securities Rule Making Board reported trades and vendor trading platform data. Level 2 includes those financial instruments that are valued using various pricing services and broker pricing information including Electronic Communication Networks and broker feeds.
Level 3: Pricing inputs include significant inputs that are generally less observable from objective sources, including the Company’s own assumptions. The fair market value for level 3 securities may be highly sensitive to the use of unobservable inputs and subjective assumptions. Generally, changes in significant unobservable inputs may result in significantly lower or higher fair value measurements.
The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification of levels for certain securities within the fair value hierarchy. There have been no transfers of assets or liabilities between fair value measurement classifications during the six months ended June 30, 2022 or 2021.
The following tables summarize the Company’s financial instruments measured at fair value on a recurring basis in accordance with the authoritative guidance for fair value measurements as of June 30, 2022 and December 31, 2021 (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| June 30, 2022 | | December 31, 2021 |
| Total Fair Value | | Level 3 | | Level 1 | | Total Fair Value | | Level 3 | | Level 1 |
Assets | | | | | | | | | | | |
Cash equivalents | | | | | | | | | | | |
Money market funds | $ | — | | | $ | — | | | $ | — | | | $ | 126 | | | $ | — | | | $ | 126 | |
Total assets | $ | — | | | $ | — | | | $ | — | | | $ | 126 | | | $ | — | | | $ | 126 | |
Liabilities | | | | | | | | | | | |
2025 Notes | | | | | | | | | | | |
Interest make-whole payment | $ | 24 | | | $ | 24 | | | $ | — | | | $ | 926 | | | $ | 926 | | | $ | — | |
Total liabilities | $ | 24 | | | $ | 24 | | | $ | — | | | $ | 926 | | | $ | 926 | | | $ | — | |
| | | | | | | | | | | |
| | | | | | | | | | | |
The fair value of the interest make-whole payment derivative liability was determined using a Monte Carlo model with the following key assumptions:
| | | | | | | | | | | | | | | |
| June 30, 2022 | | December 31, 2021 | | | | |
Volatility | 50 | % | | 50 | % | | | | |
Stock price | $1.89 per share | | $5.83 per share | | | | |
Credit spread | 22.00 | % | | 15.93 | % | | | | |
Term | 2.84 years | | 3.34 years | | | | |
Dividend yield | — | % | | — | % | | | | |
Risk-free rate | 2.98 | % | | 1.02 | % | | | | |
The following table sets forth a summary of changes in the fair value of Level 3 liabilities for the six months ended June 30, 2022 (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Balance as of December 31, 2021 | | Additions | | Conversions | | Change in fair value | | Balance as of June 30, 2022 |
Liabilities: | | | | | | | | | |
Interest make-whole payment | $ | 926 | | | $ | — | | | $ | — | | | $ | (902) | | | $ | 24 | |
INSEEGO CORP.
Notes to Condensed Consolidated Financial Statements (Unaudited)
The Company evaluated the 2025 Notes under ASC 815, Derivatives and Hedging, and identified an embedded derivative that required bifurcation. The embedded derivative is an interest make-whole payment. The estimated fair values of the interest make-whole derivative liability at June 30, 2022 and December 31, 2021 were determined using significant assumptions which include an implied credit spread rate for notes with a similar term, the expected volatility and dividend yield of the Company’s common stock and the risk-free interest rate.
Changes in the fair value of the interest make-whole payment totaling a gain of $0.9 million for the six months ended June 30, 2022 are included in the Company’s condensed consolidated statement of operations within other income (expense), net. As of June 30, 2022, the embedded derivative had a fair value of $0.02 million.
Other Financial Instruments
The Company’s financial assets and liabilities are carried at fair value or at amounts that, because of their short-term nature, approximate current fair value, with the exception of the 2025 Notes.
On May 12, 2020, the Company issued $180.4 million in aggregate principal amount of 2025 Notes, and restructured its outstanding debt as described further in Note 4. Debt. The Company carries its 2025 Notes at amortized cost adjusted for changes in fair value of the embedded derivative. As of June 30, 2022, $161.9 million in principal amount of the 2025 Notes remain outstanding. It is not practicable to determine the fair value of the 2025 Notes due to the lack of information available to calculate the fair value of such notes.
4. Debt
Asset-backed Revolving Line of Credit
On August 5, 2022, the Company entered into the Credit Agreement with Siena Lending Group LLC. The Credit Agreement establishes a secured asset-backed revolving credit facility which is comprised of a $50 million revolving Credit Facility, with a minimum draw of $4.5 million upon execution of the Credit Agreement. The Credit Facility matures on December 31, 2024. Availability under the Credit Facility is determined by a borrowing base comprised of a percentage of eligible accounts receivable and eligible inventory of the Borrowers. The Borrowers’ obligations under the Credit Agreement are guaranteed by the Company. The Loan Parties’ obligations under the Credit Agreement are secured by a continuing security interest in all property of each Loan Party, subject to certain Excluded Collateral (as defined in the Credit Agreement).
Borrowings under the Credit Facility may take the form of base rate loans or SOFR loans. SOFR loans will bear interest at a rate per annum equal to Term SOFR (as defined in the Credit Agreement) plus an adjustment based on the outstanding amount for a preceding month. If the outstanding amount for a preceding month is less than $15 million, the interest rate on the Credit Agreement is Term SOFR plus 3.50% per annum, with a Term SOFR floor of 1.00%. If the outstanding amount for a preceding month is greater than $15 million, the interest rate is calculated by Term SOFR Rate plus 4.00%, with a Term SOFR floor of 1.00%. If the outstanding amount for a preceding month is greater than $25 million, the interest rate is calculated by Term SOFR Rate plus 5.50%, with a Term SOFR floor of 1.00%. The Credit Agreement is also subject to closing costs and financial covenants.
2025 Notes
On May 12, 2020, the Company completed its registered public offering of $100.0 million aggregate principal amount of 2025 Notes and issued $